Healthcare AI investors focused on Diagnostics
Venture firms, family offices, accelerators, and corporate VCs with explicit thesis exposure to Diagnostics within healthcare AI. Includes lead investors, follow-on participants, and active angels.
The diagnostics sub-vertical encompasses the technologies, hardware, and biochemical tests used to identify diseases, medical conditions, or genetic predispositions. Innovations in this space range from AI-powered pathology software and rapid point-of-care testing devices to complex genomic sequencing panels that enable highly personalized medicine.
264
investors match
Within Diagnostics: top investment stages
HealthX Ventures
VC
T3
AI/ML in Healthcare
Biotech
Helmholtz Innovation Pool
Accelerator
AI
T3
Diagnostics
Medical Devices / MedTech
Heritage Group
PE
T3
Biotech
Care Delivery / Tech-Enabled Services
Heritas Capital
Family Office
T3
AI/ML in Healthcare
Biotech
High-Tech Gründerfonds (HTGF)
VC
AI
T3
Biotech
Diagnostics
Hitachi Ventures
Corporate VC
T3
AI/ML in Healthcare
Biotech
Hologic Ventures
Corporate VC
T3
Diagnostics
Women's & Reproductive Health
Horizons Ventures
Family Office
T3
AI/ML in Healthcare
Biotech
Hoxton Ventures
VC
T3
AI/ML in Healthcare
Biotech
Humboldt Fund
VC
T3
Biotech
Diagnostics
IAG Capital Partners
VC
T3
AI/ML in Healthcare
Biotech
IBM Ventures
Corporate VC
T3
AI/ML in Healthcare
Diagnostics
Illumina Ventures
VC
T3
AI/ML in Healthcare
Biotech
Indicator Ventures
VC
T3
AI/ML in Healthcare
Biotech
Industrifonden
VC
T3
Biotech
Diagnostics